SIHUAN PHARM (00460) Income Statement & Earnings

1.100
-0.050-4.35%

Market Closed May 15 16:07 CST

10.05BMarket Cap50.00P/E (TTM)

SIHUAN PHARM (00460) Income Statement

All

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Turnover

37.71%2.62B

20.69%1.15B

2.18%1.9B

-10.04%949.7M

-14.70%1.86B

-27.90%1.06B

-28.21%2.18B

-23.23%1.46B

23.30%3.04B

80.86%1.91B

Operating income

37.71%2.62B

20.69%1.15B

2.18%1.9B

-10.04%949.7M

-14.70%1.86B

-27.90%1.06B

-28.21%2.18B

-23.23%1.46B

23.30%3.04B

80.86%1.91B

Cost of sales

-23.77%-816.15M

-14.00%-388.95M

-16.73%-659.4M

-10.78%-341.18M

18.56%-564.9M

33.12%-307.97M

-14.10%-693.61M

-4.64%-460.51M

-10.57%-607.9M

-63.92%-440.1M

Operating expenses

-23.77%-816.15M

-14.00%-388.95M

-16.73%-659.4M

-10.78%-341.18M

18.56%-564.9M

33.12%-307.97M

-14.10%-693.61M

-4.64%-460.51M

-10.57%-607.9M

-63.92%-440.1M

Gross profit

45.11%1.8B

24.44%757.26M

-4.16%1.24B

-18.62%608.52M

-12.90%1.3B

-25.50%747.73M

-38.79%1.49B

-31.59%1B

26.95%2.43B

86.64%1.47B

Selling expenses

-44.35%-620.78M

-8.41%-231.42M

2.76%-430.06M

-0.46%-213.47M

6.13%-442.26M

7.47%-212.49M

12.22%-471.14M

11.99%-229.64M

-45.54%-536.74M

-91.13%-260.92M

Administrative expenses

33.28%-497.33M

11.83%-211.91M

-58.95%-745.43M

-13.28%-240.34M

15.07%-468.96M

33.76%-212.17M

6.76%-552.19M

-14.95%-320.31M

-20.91%-592.22M

-31.35%-278.66M

Research and development expenses

38.54%-291.27M

21.85%-152.85M

17.96%-473.93M

33.48%-195.59M

38.32%-577.66M

35.70%-294.04M

-7.89%-936.58M

-37.08%-457.27M

-19.05%-868.07M

-10.87%-333.57M

Impairment and provision

----

-1,215.43%-1.73B

---98.1M

---131.3M

----

-Impairment of property, machinery and equipment

----

---98.1M

----

-Other impairment is provision

----

-1,215.43%-1.73B

----

---131.3M

----

Special items of operating profit

-20.37%214.65M

-31.13%103.3M

-24.05%269.57M

28.06%149.98M

-3.74%354.93M

-61.58%117.12M

-21.51%368.73M

4.39%304.8M

2.04%469.78M

63.49%291.99M

Operating profit

539.53%607.12M

142.32%264.38M

-185.43%-138.13M

-25.35%109.1M

108.83%161.7M

-28.06%146.16M

-337.16%-1.83B

-77.07%203.18M

-1.93%771.95M

181.14%885.96M

Financing cost

26.68%-201.58M

20.75%-104.97M

-2.08%-274.93M

0.81%-132.46M

-27.54%-269.34M

-34.35%-133.54M

-79.95%-211.18M

-529.99%-99.4M

-1,328.15%-117.35M

-894.83%-15.78M

Special items of earning before tax

176.23%11.61M

-159.99%-2.49M

71.60%-15.23M

109.07%4.14M

33.70%-53.62M

4.32%-45.67M

49.00%-80.88M

5.85%-47.73M

-1,113.88%-158.58M

-343.60%-50.7M

Earning before tax

197.40%417.16M

916.80%156.92M

-165.59%-428.29M

41.88%-19.21M

92.40%-161.26M

-158.98%-33.05M

-527.97%-2.12B

-93.16%56.04M

-35.23%496.01M

171.24%819.48M

Tax

-435.71%-231.75M

-86.13%-90.73M

55.14%-43.26M

43.24%-48.75M

51.00%-96.43M

43.47%-85.89M

22.25%-196.79M

32.55%-151.94M

-15.56%-253.12M

-68.83%-225.27M

After-tax profit from continuing operations

139.32%185.4M

197.40%66.19M

-82.99%-471.55M

42.86%-67.96M

88.89%-257.69M

-24.02%-118.94M

-1,054.97%-2.32B

-116.14%-95.9M

-55.58%242.89M

252.25%594.22M

After-tax profit from non-continuing business

----

458.51%36.3M

----

71.01%-10.12M

----

Special items of earning after tax

----

458.51%36.3M

----

71.01%-10.12M

----

Earning after tax

139.32%185.4M

197.40%66.19M

-82.99%-471.55M

42.86%-67.96M

88.71%-257.69M

-24.02%-118.94M

-1,080.92%-2.28B

-116.14%-95.9M

-54.53%232.77M

311.92%594.22M

Minority profit

102.24%5.71M

-5.43%-36.41M

-25.15%-254.89M

50.16%-34.53M

44.71%-203.67M

49.15%-69.3M

-100.48%-368.36M

-692.03%-136.28M

-577.18%-183.74M

-200.12%-17.21M

Profit attributable to shareholders

182.94%179.7M

406.97%102.6M

-301.10%-216.66M

32.67%-33.42M

97.18%-54.02M

-222.95%-49.64M

-559.75%-1.91B

-93.40%40.38M

-12.01%416.51M

307.64%611.42M

Basic earnings per share

184.19%0.0197

408.33%0.0111

-303.45%-0.0234

32.08%-0.0036

97.17%-0.0058

-223.26%-0.0053

-564.25%-0.2052

-93.34%0.0043

-11.60%0.0442

308.86%0.0646

Diluted earnings per share

184.19%0.0197

408.33%0.0111

-303.45%-0.0234

32.08%-0.0036

97.17%-0.0058

-223.26%-0.0053

-567.43%-0.2052

-93.30%0.0043

-12.20%0.0439

306.33%0.0642

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2025	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Turnover	37.71%2.62B	20.69%1.15B	2.18%1.9B	-10.04%949.7M	-14.70%1.86B	-27.90%1.06B	-28.21%2.18B	-23.23%1.46B	23.30%3.04B	80.86%1.91B
Operating income	37.71%2.62B	20.69%1.15B	2.18%1.9B	-10.04%949.7M	-14.70%1.86B	-27.90%1.06B	-28.21%2.18B	-23.23%1.46B	23.30%3.04B	80.86%1.91B
Cost of sales	-23.77%-816.15M	-14.00%-388.95M	-16.73%-659.4M	-10.78%-341.18M	18.56%-564.9M	33.12%-307.97M	-14.10%-693.61M	-4.64%-460.51M	-10.57%-607.9M	-63.92%-440.1M
Operating expenses	-23.77%-816.15M	-14.00%-388.95M	-16.73%-659.4M	-10.78%-341.18M	18.56%-564.9M	33.12%-307.97M	-14.10%-693.61M	-4.64%-460.51M	-10.57%-607.9M	-63.92%-440.1M
Gross profit	45.11%1.8B	24.44%757.26M	-4.16%1.24B	-18.62%608.52M	-12.90%1.3B	-25.50%747.73M	-38.79%1.49B	-31.59%1B	26.95%2.43B	86.64%1.47B
Selling expenses	-44.35%-620.78M	-8.41%-231.42M	2.76%-430.06M	-0.46%-213.47M	6.13%-442.26M	7.47%-212.49M	12.22%-471.14M	11.99%-229.64M	-45.54%-536.74M	-91.13%-260.92M
Administrative expenses	33.28%-497.33M	11.83%-211.91M	-58.95%-745.43M	-13.28%-240.34M	15.07%-468.96M	33.76%-212.17M	6.76%-552.19M	-14.95%-320.31M	-20.91%-592.22M	-31.35%-278.66M
Research and development expenses	38.54%-291.27M	21.85%-152.85M	17.96%-473.93M	33.48%-195.59M	38.32%-577.66M	35.70%-294.04M	-7.89%-936.58M	-37.08%-457.27M	-19.05%-868.07M	-10.87%-333.57M
Impairment and provision	----	----	----	----	----	----	-1,215.43%-1.73B	---98.1M	---131.3M	----
-Impairment of property, machinery and equipment	----	----	----	----	----	----	----	---98.1M	----	----
-Other impairment is provision	----	----	----	----	----	----	-1,215.43%-1.73B	----	---131.3M	----
Special items of operating profit	-20.37%214.65M	-31.13%103.3M	-24.05%269.57M	28.06%149.98M	-3.74%354.93M	-61.58%117.12M	-21.51%368.73M	4.39%304.8M	2.04%469.78M	63.49%291.99M
Operating profit	539.53%607.12M	142.32%264.38M	-185.43%-138.13M	-25.35%109.1M	108.83%161.7M	-28.06%146.16M	-337.16%-1.83B	-77.07%203.18M	-1.93%771.95M	181.14%885.96M
Financing cost	26.68%-201.58M	20.75%-104.97M	-2.08%-274.93M	0.81%-132.46M	-27.54%-269.34M	-34.35%-133.54M	-79.95%-211.18M	-529.99%-99.4M	-1,328.15%-117.35M	-894.83%-15.78M
Special items of earning before tax	176.23%11.61M	-159.99%-2.49M	71.60%-15.23M	109.07%4.14M	33.70%-53.62M	4.32%-45.67M	49.00%-80.88M	5.85%-47.73M	-1,113.88%-158.58M	-343.60%-50.7M
Earning before tax	197.40%417.16M	916.80%156.92M	-165.59%-428.29M	41.88%-19.21M	92.40%-161.26M	-158.98%-33.05M	-527.97%-2.12B	-93.16%56.04M	-35.23%496.01M	171.24%819.48M
Tax	-435.71%-231.75M	-86.13%-90.73M	55.14%-43.26M	43.24%-48.75M	51.00%-96.43M	43.47%-85.89M	22.25%-196.79M	32.55%-151.94M	-15.56%-253.12M	-68.83%-225.27M
After-tax profit from continuing operations	139.32%185.4M	197.40%66.19M	-82.99%-471.55M	42.86%-67.96M	88.89%-257.69M	-24.02%-118.94M	-1,054.97%-2.32B	-116.14%-95.9M	-55.58%242.89M	252.25%594.22M
After-tax profit from non-continuing business	----	----	----	----	----	----	458.51%36.3M	----	71.01%-10.12M	----
Special items of earning after tax	----	----	----	----	----	----	458.51%36.3M	----	71.01%-10.12M	----
Earning after tax	139.32%185.4M	197.40%66.19M	-82.99%-471.55M	42.86%-67.96M	88.71%-257.69M	-24.02%-118.94M	-1,080.92%-2.28B	-116.14%-95.9M	-54.53%232.77M	311.92%594.22M
Minority profit	102.24%5.71M	-5.43%-36.41M	-25.15%-254.89M	50.16%-34.53M	44.71%-203.67M	49.15%-69.3M	-100.48%-368.36M	-692.03%-136.28M	-577.18%-183.74M	-200.12%-17.21M
Profit attributable to shareholders	182.94%179.7M	406.97%102.6M	-301.10%-216.66M	32.67%-33.42M	97.18%-54.02M	-222.95%-49.64M	-559.75%-1.91B	-93.40%40.38M	-12.01%416.51M	307.64%611.42M
Basic earnings per share	184.19%0.0197	408.33%0.0111	-303.45%-0.0234	32.08%-0.0036	97.17%-0.0058	-223.26%-0.0053	-564.25%-0.2052	-93.34%0.0043	-11.60%0.0442	308.86%0.0646
Diluted earnings per share	184.19%0.0197	408.33%0.0111	-303.45%-0.0234	32.08%-0.0036	97.17%-0.0058	-223.26%-0.0053	-567.43%-0.2052	-93.30%0.0043	-12.20%0.0439	306.33%0.0642
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"